Solid Biosciences Inc.

(NASDAQ: SLDB) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Solid Biosciences Inc is a life science company. It is engaged in manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. Its lead product candidate, the SGT-001, is a gene transfer under development to restore functional dystrophin protein expression in patients' muscles. The company's pipeline products are the SB-001 and solid suit. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

Contact Information

Website: www.solidbio.com
Email: investors@solidbio.com
Main Phone: +1 617 337-4680
Address: 141 Portland Street
Address 2: Fifth Floor
State: MA
City / Town: Cambridge
Country: US
Postal Code: 02139

Issuer Information

Exchange: NGS
CEO: Ilan Ganot
Employees: 70
Issuer Type: CS - Common Stock
Sector/Industry: Healthcare
NAICS: Medicinal and Botanical Manufacturing(325411)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A